Cizzle Biotechnology

Developer of blood tests for early lung cancer detection

placeYork, England, United Kingdom calendar_todayFounded 2005 groups4 employees language cizzlebiotechnology.com

Registered entities

Investor mix

4 investors on record.

Investor typeCountShare
Venture capital125%
Private equity250%
Other / undisclosed125%
Coming soon